Recordati - Industria Chimica e Farmaceutica S.p.A.
- BID
51.1
- ASK
51.5
- 196 Units526 Units
- 07/24, 21:59:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
1.26%
Market Cap
10.37 Bil.
P/E Ratio
22.48
Dividend Yield
2.76 %
Earnings per Share
2.16 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 51 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 09:56:48 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 51.55 | 50.95 |
| PREV. DAY'S PRICE | 51.1 | (07/23) |
| CHANGE DAY BEFORE | -0.10 | -0.20 % |
| 52 WEEK HIGH / LOW | 54.5 (09/12) | 43.62 (03/23) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 1.89 | 2.02 | 2.16 | 3.19 | 3.73 |
DIVIDENDS PER SHARE | 1.20 | 1.27 | 1.34 | 1.48 | 1.54 |
DIVIDEND YIELD IN % | 2.46 % | 2.51 % | 2.76 % | - | - |
DIVIDEND GROWTH IN % | 4.35 % | 5.83 % | 5.51 % | - | - |
PRICE - EARNINGS RATIO | 25.80 | 25.06 | 22.48 | 16.11 | 13.77 |
PRICE - BOOK RATIO | 5.96 | 5.61 | 5.21 | - | - |
PRICE - SALES RATIO | 4.90 | 4.52 | 3.88 | - | - |
PRICE - CASH FLOW RATIO | 21.04 | 18.56 | 17.01 | - | - |
Master Data
| WKN | A0EABR |
| ISIN | IT0003828271 |
| SYMBOL | RER1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Recordati |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 203.43 Mil. |
| MARKET CAPITALISATION | 10.37 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.00 % | 0.39 % | 3.11 % | 9.47 % | -1.26 % | 22.40 % | 0.24 % | 5.97 % |
| HIGH | 51.45 | 51.90 | 52.25 | 52.25 | 54.50 | 59.55 | 59.55 | 52.25 |
| LOW | 50.50 | 50.50 | 48.74 | 43.62 | 43.62 | 42.46 | 34.73 | 43.62 |
Dividende
pro Aktie
Company profile
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.
Structured products for Recordati - Industria Chimica e Farmaceutica S.p.A.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.